Dumbrava EE, Shapiro GI, Parikh AR, Johnson ML, Tolcher AW, Thompson JA, El-Khoueiry AB, Vandross AL, Kummar S, Shepard DR, LeDuke K, Sheehan L, Alland L, Haque A, Jalota D, Fellous M, Schram AM (2026) Phase 1 study of rezatapopt, a p53 reactivator, in TP53 Y220C–mutated tumors. New England Journal of Medicine 394(9):872–883.
https://doi.org/10.1056/NEJMoa2508820. …